- Report
- January 2024
- 201 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- October 2023
- 85 Pages
United States
From €4277EUR$4,850USD£3,703GBP
- Report
- August 2023
- 180 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- July 2023
- 100 Pages
Global
From €4277EUR$4,850USD£3,703GBP
- Report
- September 2022
Global
€4990EUR$6,061USD£4,471GBP
- Report
- August 2022
- 67 Pages
Global
- Report
- June 2022
- 220 Pages
Global
From €3043EUR$3,450USD£2,634GBP
- Report
- November 2020
- 450 Pages
Global
From €4321EUR$4,900USD£3,741GBP
- Report
- October 2020
- 85 Pages
Global
€19402EUR$22,000USD£16,796GBP
- Report
- September 2020
- 700 Pages
Global
From €4321EUR$4,900USD£3,741GBP
- Drug Pipelines
- September 2019
- 141 Pages
Global
€8819EUR$10,000USD£7,635GBP
- Report
- August 2019
- 42 Pages
Global
€2641EUR$2,995USD£2,287GBP
- Report
- November 2022
- 71 Pages
Global
From €3087EUR$3,500USD£2,672GBP
- Report
- August 2022
- 1834 Pages
Global
From €2205EUR$2,500USD£1,909GBP
- Report
- August 2024
- 84 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- January 2024
- 174 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- November 2024
- 120 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- February 2024
- 127 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- October 2023
- 77 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- August 2023
- 98 Pages
Global
From €3500EUR$4,251USD£3,136GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more